Neuroperfusion Buoyed by Cash Infusion

IRVINE — Privately held Neuroperfusion Inc., which is developing a catheter-based treatment for acute strokes, said it is receiving a cash infusion from an Indianapolis company as part of a strategic alliance.

Guidant Corp., which provides cardiological and surgical products and services, will get an undisclosed equity stake in the Irvine medical devices company and a seat on Neuroperfusion’s board.

Neuroperfusion has also raised venture capital financing from a syndicate consisting of Mayfield Fund and New Enterprise Associates.